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A Pilot Study of Audio-Visual Stimulation as a Self-Care Treatment for Insomnia
in Adults with Insomnia and Chronic Pain
Abstract
This pilot study tested the efficacy of an audio-visual stimulation (AVS) program for the promotion of
sleep in individuals with chronic pain. Insomnia and chronic pain are common comorbid conditions and
their relationship has been viewed as bidirectional. Recent studies suggest a relatively dominant role of
sleep in this dyad. The premise of this pilot study was that AVS enhances low frequency while reducing
high frequency brain activity resulting in decreased hyperarousal and improved sleep with potential
consequent reduction in pain. We conducted a pilot intervention study of AVS using a pre-post design.
Participants self-administered a 30-min AVS program nightly at bedtime for 1 month. Sleep and pain were
assessed at baseline and at the conclusion of the 4-week intervention phase. Nine adults (mean age 33 ±
15.8 years; female, 89 %) completed the study. After using the AVS device for 4 weeks, significant
improvement was seen in reported insomnia (ISI, p = 0.003), pain severity (BPI, p = 0.005), and pain
interference with functioning (BPI, p = 0.001). Large effect sizes (Partial η2 0.20-0.94) (Cohen's d
0.44-1.45) were observed. The results of this pilot study suggest that the AVS program may be efficacious
in decreasing both insomnia and pain symptoms. In order to better assess the efficacy of AVS for sleep
promotion and possible pain reduction, more definitive randomized controlled trials will be needed. These
should include appropriate sample sizes, objective measures of sleep and pain, and longitudinal followup.
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Abstract
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This pilot study tested the efficacy of an Audio-visual Stimulation (AVS) program for the
promotion of sleep in individuals with chronic pain. Insomnia and chronic pain are common
comorbid conditions and their relationship has been viewed as bidirectional. Recent studies
suggest a relatively dominant role of sleep in this dyad. The premise of this pilot study was that
AVS enhances low frequency while reducing high frequency brain activity resulting in decreased
hyperarousal and improved sleep with potential consequent reduction in pain. We conducted a
pilot intervention study of AVS using a pre-post design. Participants self-administered a 30minutes AVS program nightly at bedtime for one month. Sleep and pain were assessed at baseline
and at the conclusion of the 4-week intervention phase. 9 adults (mean age 33 ± 15.8 years;
female, 89%) completed the study. After using the AVS device for 4 weeks, significant
improvement was seen in reported insomnia (ISI, p=.003), pain severity (BPI, p=.005), and pain
interference with functioning (BPI, p=.001). Large effect sizes (Partial Eta2: .20–.94)(Cohen’s d:
0.44–1.45) were observed. The results of this pilot study suggest that the AVS program may be
efficacious in decreasing both insomnia and pain symptoms. In order to better assess the efficacy
of AVS for sleep promotion and possible pain reduction, more definitive randomized controlled
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trials will be needed. These should include appropriate sample sizes, objective measures of sleep
and pain, and longitudinal follow-up.
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Introduction
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Chronic pain affects 1 in 3 Americans (Johannes, Le, Zhou, Johnston, & Dworkin, 2010),
and 67–88% of adults with chronic pain experience some form of sleep disturbance (Morin,
LeBlanc, Daley, Gregoire, & Merette, 2006). This striking level of comorbidity has
suggested to many that the relationship between pain and sleep may be bi-directional
(Alsaadi et al., 2014; Finan, Goodin, & Smith, 2013; Jansson-Frojmark & Boersma, 2012;
McCracken & Iverson, 2002; Okifuji & Hare, 2011). That is, pain may serve to precipitate
and perpetuate sleep continuity disturbance; and that sleep initiation and maintenance
problems and/or sleep loss may serve to exacerbate or reduce the individual’s tolerance of
chronic pain. Further, chronic insomnia may increase the risk for the development of other
medical and psychiatric conditions (Matteson-Rusby, Pigeon, Gehrman, & Perlis, 2010)
which, in turn, as comorbid conditions, increase the risk for the development, or
exacerbation, of chronic pain. These issues, when taken together, strongly suggest that sleep
disturbance, in the context of chronic pain, should be targeted for treatment.
Sleep and Chronic Pain

NIH-PA Author Manuscript

As noted above, the relationship between insomnia and chronic pain has been viewed as bidirectional. Recent studies provide laboratory based evidence that individuals with primary
insomnia and insomnia comorbid with chronic pain process pain abnormally (Haack et al.,
2012). For example, those with primary insomnia experienced spontaneous pain more
frequently and intensely, exhibited a higher sensitivity to evoked heat and pressure pain, and
had a dysfunctional pain inhibition system. These findings are consistent with the emerging
hypothesis that insomnia is associated with increased pain perception and/or amplification.
Importantly, findings from a recent systematic review show that sleep impairment not only
predicts new onset and the continuation of chronic pain; sleep is a stronger predictor of
chronic pain than chronic pain is to sleep impairment (Finan et al., 2013). This hypothesis is
further supported by a longitudinal 13-year study in which sleep disturbances at baseline
strongly predicted chronic or onset of radiating low back pain over the course of
longitudinal follow up (Lusa, Miranda, Luukkonen, & Punakallio, 2014). Finally, results
from a recent study show that short-term improvements in sleep predicted long-term
improvements in chronic pain, insomnia symptoms, and fatigue (McCurry et al., 2014;
Vitiello et al., 2014). Taken together these findings suggest that improving sleep might
improve pain outcomes (Finan et al., 2013; M.T. Smith & Haythornthwaite, 2004; Turk &
Cohen, 2010).
Current treatment options for sleep include pharmacological treatment and Cognitive
Behavioral Therapy for Insomnia (CBT-I) (M. Perlis, Gehrman, & Riemann, 2008; Schutte-
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Rodin, Broch, Buysse, Dorsey, & Sateia, 2008). Medical treatment with hypnotics (e.g.,
benzodiazepines and benzodiazepine receptor agonists) has been shown to have good
efficacy, safety, and durability for up to 12 months. Clinical benefits, however, do not
persist after treatment discontinuation and some patients may experience loss of
effectiveness and/or psychological dependence with extended use of hypnotics (Nowell et
al., 1997; Roth, Walsh, Krystal, Wessel, & Roehrs, 2005). CBT-I is considered a gold
standard non-pharmacological treatment, yielding treatment effects comparable to or
exceeding those observed for medications (Jungquist et al., 2010b; Mitchell, Gehrman,
Perlis, & Umscheid, 2012; M. T. Smith et al., 2002; Wang, Wang, & Tsai, 2005). Further,
there is evidence that CBT-I for insomnia comorbid with chronic pain is as, or more,
efficacious than when the treatment is applied to patients with “Primary Insomnia”
(Jungquist et al., 2010a; Jungquist et al., 2012; Vitiello, Rybarczyk, Von Korff, & Stepanski,
2009).

NIH-PA Author Manuscript

One area in insomnia research that has remained under studied is use of self-care approaches
that people can use at the home setting to promote sleep. Specifically, brainwave
entrainment through light and sound stimulation is an intervention that may have potential to
promote relaxation and sleep, but its potential efficacy for improving sleep has not been well
explored.
Audio-visual Stimulation (AVS)
The study of the Audio-visual Stimulation (AVS) can be traced back to 1930s. The term
AVS is often used interchangeably with “light and sound stimulation” and “audio photic
stimulation.” In 1934, with the availability of encephalogram, the impact of photic
stimulation on brain activity was documented in a study in which increased brain activity
was found to correspond to the frequency of a given photic stimulation (Adrian & Matthews,
1934). During the following decade, several investigators reported brain activity changes in
response to photic stimulation, noting that the rhythm of brain activity tended to assume the
rhythm of the photic stimulus, which was termed “entrainment” (Bartley, 1937; Jasper,
1936).

NIH-PA Author Manuscript

Brain activity AVS entrainment to slow frequencies to promote deep relaxation has been
reported clinically and in several older studies. In 1980, one of the biofeedback/
neurofeedback pioneers, Dr. Thomas Budzynski reported using light and sound stimulation
(stimulation frequency unspecified) to assist his clients in successfully achieving and
maintaining theta state (3–6 Hz, pre Stage 1 sleep state) during psychotherapy sessions
(Budzynski, 1992; Hutchison, 1990). A study by Harris demonstrated that light and sound
stimulation (frequency undefined) promoted better sleep for his AIDS/HIV patients
(Hutchison, 1990). In addition, a study by Hauri found that AVS closed-loop training,
discussed further below, in the sensory motor rhythm (SMR, 12–15 Hz) promoted sleep in
people who were physically relaxed but cognitively preoccupied (P. Hauri, 1981; P. J.
Hauri, Percy, Hellekson, Hartmann, & Russ, 1982). Of note, Harris’ and Hauri’s studies are
two of the few in the AVS literature that document an effect of AVS on sleep.
Audio-visual stimulation (AVS) is a promising self-care intervention option for insomnia
that uses preprogrammed light and sound patterns to potentiate sleep-related EEG activity
Appl Psychophysiol Biofeedback. Author manuscript; available in PMC 2015 December 01.
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(delta-theta 1–8 Hz) (Budzynski, Budzynski, Sherlin, & Tang, 2011). The AVS devices are
inexpensive and readily available without a prescription. Although the AVS mechanism is
not fully understood, it is thought that the auditory and visual elements of AVS stimulation
modulate endogenous brain activity by activating retinal cells in the eyes and pressuresensitive cilia within the cochlea of the ears. The evoked electrical potential is then
transmitted via neural pathways (audio signals via the medial geniculate; visual signals via
the lateral geniculate) to the thalamus where audio and visual sensory information is
processed. From the thalamus, the entrained electrical activity is propagated through the
cortical thalamic loop to the rest of limbic system and the cerebral cortex (Budzynski et al.,
2011; Collura & Siever, 2008) (Figure 1). Importantly, reported adverse effects are minimal;
the only known contraindication for adults is a history of a seizure disorder (Rodin, Daly, &
Bickford, 1955). While the neural mechanism for AVS remains in debate, a study with six
healthy adults demonstrated that repetitive training over a period of 2 months (25 sessions of
AVS ramping from 18 down to 2 Hz over 20 minutes, with subjects laying in darkened room
with eyes closed) significantly reduced beta and gamma activities and increased the theta/
alpha ratio (a brainwave state that is conducive for sleep onset). The findings suggested that
with repeated training, AVS cultivates an adaptive self-regulation process and provides
exogenous signals to entrain cortical activity to slower frequencies (Teplan, Krakovska, &
Stolc, 2006, 2011).

NIH-PA Author Manuscript

One current line of thought about the ethology and pathophysiology of insomnia, is that
chronic insomnia is a hybrid state (hyperarousal) wherein the subject is less disengaged from
the environment owing to conditioned cortical arousal and/or local neuronal wakefulness
(Buysse, Germain, Hall, Monk, & Nofzinger, 2011; M. L. Perlis, Giles, Mendelson, Bootzin,
& Wyatt, 1997). This hypothesized state suggests that interventions that facilitate EEG
slowing (via feedback, entrainment, conditioning, etc.) may promote improved sleep
induction and maintenance. The purpose of this study was to examine the feasibility of a 30
minutes self-administered AVS program for sleep promotion in adults with insomnia and
chronic pain in the community setting.

Methods
NIH-PA Author Manuscript

This was a pilot intervention study using a pre- and post- design. Thirteen participants were
recruited from the community sites in Philadelphia and Seattle, through flyers posted at
community centers and advertisement placed in the local newspaper. Inclusion criteria were
adults 21 years and older, having nonmalignant pain most days for more than 6 months,
difficulty sleeping at least 3 nights per week for 3 months, a score of 8 or higher on the
Insomnia Severity Index (ISI), and a score between 3 and 10 on the ‘worst pain’ item of the
Brief Pain Inventory (BPI). Exclusion criteria were seizure disorder, night shift worker,
known photosensitivity, cognitive impairment (assessed through in-person interview by
trained research staff), severe psychiatric disorder, and history of a sleep disorder other than
insomnia, such as restless leg syndrome, sleep apnea or narcolepsy. Sleep apnea was selfreported or presumed based on a score higher than 0.5 on the Multivariate Apnea Prediction
(MAP) index (Maislin et al., 1995). Restless Leg Syndrome was assessed with the 4 item
simplified version of International Restless Legs Syndrome scale (IRLS)(Walters et al.,
2003; Wunderlich et al., 2005). This pilot study was approved by the University of
Appl Psychophysiol Biofeedback. Author manuscript; available in PMC 2015 December 01.
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Pennsylvania and Seattle University Institutional Review Boards. Inform consent was
obtained prior to data collection.
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Measures
Insomnia Severity Index (ISI)—The ISI is a validated 7-item (0–4) scale that measures
insomnia severity. Norms are: 0–7 = no clinically significant insomnia; 8–14 = sub threshold
insomnia; 15–21 = clinical insomnia (moderate severity); 21–28 = clinical insomnia
(severe). The ISI has internal consistency (alpha =0.90), sensitivity (86%) and specificity
(87%); the scale is well-established and sensitive to changes with intervention (Bastien,
Vallieres, & Morin, 2001; Morin, Belleville, Belanger, & Ivers, 2011).
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Sleep diary—The diary is a two-page log with standard questions about the quantity and
quality of the previous night of sleep, including Time to Bed, Sleep Latency, Number of
Awakenings, Wake After Sleep Onset time (WASO), Total Sleep Time, and Time out of
Bed. The diary also includes questions about the causes of sleep difficulties if any, caffeine
and alcohol consumption, daytime napping, exercise, health issues, hypnotic use and the
AVS adherence. The one-week sleep diary was completed once at baseline and again upon
completion of the intervention.
Brief Pain Inventory (BPI)—The BPI (short form) is a 9-item assessment of pain
severity, impact of pain on daily function, location of pain, pain medications and amount of
pain relief in the past 24 hours. Administration takes 5 minutes. The scoring of the pain data
yields 2 categories: 1) Pain Severity which is a combination of the four pain items (pain
now, average pain, worst pain and least pain in the last 24 hours) [0=no pain, 10=pain as bad
as you can imagine], and 2) Pain Interference with 7 daily activities/functioning including
general activity, walking, work, mood, enjoyment of life, relations with others, and sleep
[0=pain does not interferes, 10=pain completely interferes]. Reliability is adequate
(Cronbach alpha = 0.77 – 0.91). The BPI has been tested in various pain conditions such as
cancer pain, depressive disorders, fibromyalgia, osteoarthritis, etc. In addition, BPI is
available in more than 36 languages and has been validated by confirming the consistency of
its 2-factor structure (Cleeland & Ryan, 1994; Keller et al., 2004).

NIH-PA Author Manuscript

Patient Health Questionnaire (PHQ-9)—The PHQ-9 is a well-established scale
measuring mood state. The items ask how often in the past 2 weeks the individual has been
bothered by symptoms of depression. Scores on the PHQ-9 range from 0 to 27 (1–4 minimal
depression; 5–9 mild depression; 10–14 moderate depression; 15–19 moderately severe
depression; and 20–27 severe depression (Kroenke, Spitzer, & Williams, 2001).
Multivariable Apnea Prediction Index (MAP)—The MAP is a 13 items survey that
screens for prediction of apnea. The survey assesses common symptoms of apnea such as
loud snoring, gasping during sleep, breathing difficulty, and excessive daytime sleepiness.
Participants were asked to rate the frequency of these identified symptoms on a numeric
scale (0 = never; 4 = always, 5–7 times/week; and do not know). The score is then entered
into a formula along with covariates (age, gender, and body mass index) for further
computation. A MPA score higher than 0.5 suggests likelihood of sleep apnea (Maislin et

Appl Psychophysiol Biofeedback. Author manuscript; available in PMC 2015 December 01.

Tang et al.

Page 6

al., 1995). In this study, the MPA was assessed at the initial interview. People who scored
higher than 0.5 on MPA were excluded from participating in this study.
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International Restless Legs Syndrome scale (IRLS)—The IRLS (short form) is a 4
item questionnaire that indexes typical symptoms of restless leg syndrome during the day
and sleep (i.e., discomfort sensation in legs, urgency to move or rub legs to relieve
discomfort, symptoms worsen when resting). The response option for each item is yes or no
(Walters et al., 2003). The IRLS (short form) was used as a screening tool in this study. If a
participant answered yes to all 4 questions, then they were not eligible to participate in this
study.
Demographic data, brief health history (i.e., smoking, alcohol, drug use) and medication
data (name, dosage, frequency, duration, indication, and medication changes) were also
collected and used to describe the sample.
Procedure
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At the initial meeting, participants completed the ISI, BPI, and PHQ-9 and were instructed
to record their sleep patterns (sleep diary) for 1 week during the baseline period; which is a
typical length of baseline observation in sleep research. After a 1-week baseline, they were
trained to use the AVS program at bedtime and to record their sleep pattern in a sleep diary
for 1 month. The AVS program [Procyon by MindPlace] consists of 30-minutes of light
flickering (goggles) and sound pulsing (headphones) that gradually descends from alpha (8
Hz) to delta (1 Hz) frequencies. Weekly phone calls were used to address participants’
questions and assess frequency of usage. The ISI, BPI, and PHQ-9 were measured again
upon completion of the 1 month intervention.
Data Analysis
The raw data were screened for accuracy, missing values, outliers, and distributional
properties prior to analysis (SPSS V21). The sample was characterized using descriptive
statistics of demographic and baseline variables. Repeated paired sample T-tests were used
to examine pre- and post- intervention differences. The effect size was examined using both
ANOVA partial Eta2 and Cohen’s d.
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Results
Thirteen adults were enrolled and nine (mean age 33±16, 89% women) (7 from Seattle, 2
from Philadelphia) completed the study. Of the four participants who withdrew from the
study, one reported sensitivity to the light stimulation even at the dimmest intensity, two did
not like to wear any foreign object (goggles and ear buds) during sleep, and one declined to
give a reason. None of the withdrawn participants reported serious adverse effects. There
were no significant differences on the demographic characteristics and baseline measures
between those who completed and those who withdrew.
Data were collected between November 2012 and March 2013. At baseline, the mean
insomnia severity score (ISI) at was 19.2 ± 3.9, in the clinical insomnia moderate range. The
total sleep time by self-reported sleep diary was 403.4 ± 70.2 minutes. Mean ratings for
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worst pain in the last 24 hours (7.0 ± 1.1), pain interference with sleep (8.0 ± 1.6), pain
interference with the ability to enjoy life (5.4 ± 1.8), and the impact of pain on mood (5.2±
2.3) were all elevated. The majority of the participants reported having back pain (67%); the
rest reported pain that was disease related (i.e., congenital abdominal condition (11%),
fibromyalgia (11%), and arthritis (11%). The mood measure (PHQ-9) at baseline was 11.9 ±
5.6, in the moderate depression range.

NIH-PA Author Manuscript

After the one-month AVS intervention (with self-reported adherence to the AVS of 94%)
significant improvement was observed for insomnia (ISI, p=.003). The sleep diary measures
(sleep latency, WASO, total sleep time, and sleep efficiency), although not statistically
significant, showed trends in the direction of improvement (Table 1). Before Bonferroni
adjustment for multiple comparisons, significant improvement in pain severity (BPI, p=.
005), pain interference with daily functioning (BPI, p=.001), worst pain (BPI, p=.004),
ability to sleep through pain (BPI, p=.015), pain interference with the mood (BPI, p=.012),
the degree to which pain interfered with the enjoyment of life (BPI, p=.043), and depression
(PHQ-9, p=.035) were observed. Thesefindings suggested large effect sizes (Partial Eta2,
range 0.20–0.94)(Cohen’s d, range 0.44–1.45). When Bonferroni correction was performed,
Insomnia Severity Index & BPI Pain Interference Functional remained statistically
significant (Table 1).

Discussion
The results of this pilot study of a small sample with comorbid insomnia and pain suggest
that the AVS program ramping from 8 to 1 Hz over the course of 30 minutes may be
efficacious in decreasing insomnia symptoms. In addition to the positive changes in sleep,
improvements were also observed in pain although pain was not directly treated. This result
indirectly supports the emerging hypothesis that sleep may have a more prominent role than
pain in the comorbid dyad (Finan et al., 2013) and illustrates the feasibility of this
intervention approach.

Limitations
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While the results of this preliminary study were encouraging, taking into account that sleep
and pain are highly subjective phenomena, the interpretation of the findings is limited by the
small sample size, lack of a control group, the lack of objective measures of sleep and pain,
and the pre post design. In addition, the high self-reported adherence rate for AVS usage
could be indicative of highly committed subjects or social desirability effects. To further the
understanding of the AVS intervention in sleep promotion and pain reduction, we
recommend that future study include a randomized controlled design with a larger sample
size, an objective measure of sleep and pain, and longitudinal follow up.

Implications
This pilot study is the first to examine the efficacy of a 30 minutes self-administered
portable in-home AVS self-care intervention for sleep induction in adults with chronic pain.
Considering that treatment options for insomnia are somewhat limited, AVS could serve as

Appl Psychophysiol Biofeedback. Author manuscript; available in PMC 2015 December 01.

Tang et al.

Page 8

an initial intervention in a stepped care approach for the management of insomnia in people
with chronic pain.
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Figure 1.

AVS Auditory and Visual Pathways
In AVS, the visual stimulation (flickering light) is delivered through goggles with lightemitting diodes (LEDs) and the audio stimulation is delivered through headphones.
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35.7 ± 17.2
403.4 ± 70.2
80.5 ± 6.6
5.0 ± 1.2
5.39 ± 1.9
11.9 ± 5.6

Sleep Diary wakes after sleep onset (WASO)

Sleep Diary total sleep time

Sleep Diary sleep efficiency

BPI Pain Severity (4 severity items)

BPI Pain Interference Items (7 functional items)

PHQ-9 Depression

9.0 ± 2.8

3.8 ± 2.0

4.0 ± 1.6

88.5 ± 4.2

444.0 ± 106.5

22.6 ± 19.6

56.6 ± 28.3

12.8 ± 5.0

Post-test

Significance after Bonferroni adjustment – P value at 0.05 / 8 items: 0.006

*

68.8 ± 27.3

19.2 ± 3.9

Sleep Diary sleep latency

Insomnia Severity Index

Pre-test

.80

.94

0.001*
0.035

.50

.48

.11

.47

0.047

0.129

0.463

0.090

.20

.79

0.003*
0.456

Partial Eta2

Significance

0.66

0.84

0.71

1.45

0.45

0.71

0.44

1.45

Cohen’s d

AVS for Sleep Promotion in Adults with Chronic Pain (N=9) Mean Scores at Baseline Compared with Mean Scores in Post-Testing 4 Weeks Later
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